I have been sitting on the sidelines for a while,
Post# of 72440
(Total Views: 639)
Posted On: 05/16/2019 6:26:06 PM
I have been sitting on the sidelines for a while, but paying attention to the board here and there. Figure that today's news is a worthwhile time to ponder out load and post some brain droppings:
Last year IPIX first indicated that they were in talks with parties interested in B-OM. Then it evolved into the August non-binding term sheet for B-OM AND IBD indications. Given that IBD indications is a broad spectrum which includes UP/UC, I cant help but think that the new term sheet, now specifically for UP/UC, indicates that the potential partner is a different company. Because I just cant see why the first potential partner would drop B-OM and IBD indications and re-sign a new sheet just for UP/UC with later options of the irst right of refusal for the other IBD indications. Plus I dont recall the August announcements indicating a Global pharma company as the group for the first term sheet. (I think I may just be recalling that incorrectly, so if someone can confirm or deny that I'd appreciate it. I dont have the time to go do the research just for the sake of this post. I have a day job that doesn't include being paid to troll SMBs.)
Regardless, it seems logical to me that this new sheet is with a new partner and poses a few scenarios:
1) The offer with this new partner is better than the first term sheet for B-OM with the IBD indications as an adder. So IPIX is going after a more lucrative deal.
2) This negates the B-OM term sheet since IBD is now off the table. Which either allows IPIX to have more leverage with potential B-OM partner for a better deal. Leaves IPIX to negotiate B-OM on its own with other suitors. Or the expected upfront money will allow IPIX to keep going it alone with B-OM to progress the trails and make the asset even more valuable.
3) IPIX has two term sheets and two potential partners for the specified indications.
I am sure that reality is likely way different then my musings, but at least we know that another significant concrete step has been made by IPIX on the road to success.
I cant wait for more news to develop!!!!!! Still holding long and strong on this one!!!! (oh and I convinced my brother in-law to by some thousands of shares down in the .10's. So he's stoked about the news too.)
Last year IPIX first indicated that they were in talks with parties interested in B-OM. Then it evolved into the August non-binding term sheet for B-OM AND IBD indications. Given that IBD indications is a broad spectrum which includes UP/UC, I cant help but think that the new term sheet, now specifically for UP/UC, indicates that the potential partner is a different company. Because I just cant see why the first potential partner would drop B-OM and IBD indications and re-sign a new sheet just for UP/UC with later options of the irst right of refusal for the other IBD indications. Plus I dont recall the August announcements indicating a Global pharma company as the group for the first term sheet. (I think I may just be recalling that incorrectly, so if someone can confirm or deny that I'd appreciate it. I dont have the time to go do the research just for the sake of this post. I have a day job that doesn't include being paid to troll SMBs.)
Regardless, it seems logical to me that this new sheet is with a new partner and poses a few scenarios:
1) The offer with this new partner is better than the first term sheet for B-OM with the IBD indications as an adder. So IPIX is going after a more lucrative deal.
2) This negates the B-OM term sheet since IBD is now off the table. Which either allows IPIX to have more leverage with potential B-OM partner for a better deal. Leaves IPIX to negotiate B-OM on its own with other suitors. Or the expected upfront money will allow IPIX to keep going it alone with B-OM to progress the trails and make the asset even more valuable.
3) IPIX has two term sheets and two potential partners for the specified indications.
I am sure that reality is likely way different then my musings, but at least we know that another significant concrete step has been made by IPIX on the road to success.
I cant wait for more news to develop!!!!!! Still holding long and strong on this one!!!! (oh and I convinced my brother in-law to by some thousands of shares down in the .10's. So he's stoked about the news too.)
(2)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼